This inventor holds 1 USPTO granted patent. Top assignee: Life Technologies Corporation. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Steward Shuman: Innovator in Molecular Cloning
Introduction
Steward Shuman is a notable inventor based in New York, NY (US). He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid manipulation. His innovative work has led to the development of methods that enhance the efficiency of molecular cloning.
Latest Patents
Steward Shuman holds a patent for "Methods and reagents for molecular cloning." This invention provides compositions, methods, and kits for covalently linking nucleic acid molecules. The methods include a strand invasion step, which simplifies the process of covalently linking double-stranded nucleic acid molecules. For instance, his method involves contacting a first double-stranded nucleic acid molecule, which has a topoisomerase linked to a 3' terminus of one end and a single-stranded 5' overhang at the same end, with a second double-stranded nucleic acid molecule having a blunt end. This innovative approach allows for the hybridization of the 5' overhang to a complementary sequence of the blunt end of the second nucleic acid molecule, enabling the topoisomerase to covalently link the double-stranded nucleic acid molecules. His methods are noted for being simpler and more efficient than previous techniques.
Career Highlights
Steward Shuman is associated with Life Technologies Corporation, where he applies his expertise in molecular biology. His work has been instrumental in advancing the capabilities of genetic engineering and biotechnology.
Collaborations
Some of his notable coworkers include Jonathan D Chesnut and Knut R Madden. Their collaborative efforts contribute to the innovative environment at Life Technologies Corporation.
Conclusion
Steward Shuman's contributions to molecular cloning represent a significant advancement in the field of biotechnology. His patented methods and reagents are paving the way for more efficient genetic manipulation techniques.
